Get started
Author

Masato Komoda

Mice lacking a transcriptional corepressor Tob are predisposed to cancer
2003 · Yutaka Yoshida, Takahisa Nakamura, et al. · Genes & Development · 122
PDF
Irinotecan monotherapy as third-line or later treatment in advanced gastric cancer
2017 · Akitaka Makiyama, Kohei Arimizu, et al. · Gastric Cancer · 63
PDF
Specific inhibitor of puromycin-sensitive aminopeptidase with a homophthalimide skeleton: identification of the target molecule and a structure–activity relationship study
2001 · Masato Komoda, Hiroki Kakuta, et al. · Bioorganic & Medicinal Chemistry · 59
Human STEAP3 maintains tumor growth under hypoferric condition
2011 · Taichi Isobe, Eishi Baba, et al. · Experimental Cell Research · 46
Novel Small Molecule Nonpeptide Aminopeptidase N Inhibitors with a Cyclic Imide Skeleton
1999 · Rumiko Shimazawa, Hisae Takayama, et al. · Journal of enzyme inhibition · 34
PDF
Hypoalbuminemia for the prediction of venous thromboembolism and treatment of direct oral anticoagulants in metastatic gastric cancer patients
2019 · Kotoe Takayoshi, Hitoshi Kusaba, et al. · Gastric Cancer · 28
PDF
Methylation of drug resistance‐related genes in chemotherapy‐sensitive Epstein–Barr virus‐associated gastric cancer
2019 · Hirofumi Ohmura, Mamoru Ito, et al. · FEBS Open Bio · 24
PDF
Safety and Tolerability of Vandetanib in Japanese Patients With Medullary Thyroid Cancer: a Phase I/Ii Open-Label Study
2016 · Keita Uchino, Masato Komoda, et al. · Endocrine Practice · 18
Reduced dose of salvage-line regorafenib monotherapy for metastatic colorectal cancer in Japan.
2015 · Gen Hirano, Akitaka Makiyama, et al. · PubMed · 18
Association of ERBB2 Copy Number and Gene Coalterations With Trastuzumab Efficacy and Resistance in Human Epidermal Growth Factor Receptor 2–Positive Esophagogastric and Gastric Cancer
2022 · Kaori Hino, Tomohiro Nishina, et al. · JCO Precision Oncology · 17
Survival in Older Japanese Adults With Advanced Cancer Before and After Implementation of a Geriatric Oncology Service
2023 · Tomohiro F. Nishijima, Mototsugu Shimokawa, et al. · JCO Oncology Practice · 15
Programmed death-ligand 1 expression is associated with fibrosarcomatous transformation of dermatofibrosarcoma protuberans
2017 · Kenji Tsuchihashi, Hitoshi Kusaba, et al. · Molecular and Clinical Oncology · 14
PDF
Indications for conversion hepatectomy for initially unresectable colorectal cancer with liver metastasis
2021 · Masahiko Sugiyama, Hideo Uehara, et al. · Surgery Today · 12
Analysis of adverse events of bevacizumab-containing systemic chemotherapy for metastatic colorectal cancer in Japan.
2014 · Taichi Isobe, Keita Uchino, et al. · PubMed · 12
Pertuzumab plus trastuzumab and real-world standard of care (SOC) for patients (pts) with treatment refractory metastatic colorectal cancer (mCRC) with HER2 (ERBB2) amplification (amp) confirmed by tumor tissue or ctDNA analysis (TRIUMPH, EPOC1602).
2021 · Wataru Okamoto, Yoshiaki Nakamura, et al. · Journal of Clinical Oncology · 11
Potent Homophthalimide-Type Inhibitors of B16F10/L5 Mouse Melanoma Cell Invasion.
1999 · Hiroyuki KAGECHIKA, Masato KOMODA, et al. · Biological and Pharmaceutical Bulletin · 10
PDF
Immunosuppressant therapy successfully improved regorafenib-induced severe hepatic injury in a patient with metastatic gastrointestinal stromal tumor: A case report
2015 · MIYUKI KUWAYAMA, KEITA UCHINO, et al. · Oncology Letters · 9
PDF
Interstitial pneumonia during bevacizumab-based chemotherapy for colorectal cancer
2014 · Shingo Tamura, Hitoshi Kusaba, et al. · Medical Oncology · 9
Preparation of Novel Specific Aminopeptidase Inhibitors with a Cyclic Imide Skeleton
2000 · Hiroyasu TAKAHASHI, Masato KOMODA, et al. · YAKUGAKU ZASSHI · 9
PDF
Prevalence and clinicopathological features of microsatellite instability-high metastatic or recurrent gastric and esophagogastric junction cancer: WJOG13320GPS
2024 · Azusa Komori, Shuichi Hironaka, et al. · Gastric Cancer · 8
PDF
Clinical Impact of Primary Tumor Location in Metastatic Colorectal Cancer Patients Under Later-Line Regorafenib or Trifluridine/Tipiracil Treatment
2021 · Hiromichi Nakajima, Shota Fukuoka, et al. · Frontiers in Oncology · 7
PDF
Second-line chemotherapy after early disease progression during first-line chemotherapy containing bevacizumab for patients with metastatic colorectal cancer
2021 · Shun Yamamoto, Kengo Nagashima, et al. · BMC Cancer · 6
PDF
Survival Benefit of Crossover Administration of Regorafenib and Trifluridine/Tipiracil Hydrochloride for Patients With Metastatic Colorectal Cancer: Exploratory Analysis of a Japanese Society for Cancer of the Colon and Rectum Multicenter Observational Study (REGOTAS)
2021 · Keigo Chida, Daisuke Kotani, et al. · Frontiers in Oncology · 6
PDF
Biomarker study for trastuzumab continuation beyond progression in a randomized phase II trial of weekly paclitaxel±trastuzumab in patients with HER2-positive advanced gastric or gastro-esophageal junction cancer refractory to trastuzumab combined with fluoropyrimidine and platinum (WJOG7112G).
2018 · Yasutaka Sukawa, Akitaka Makiyama, et al. · Journal of Clinical Oncology · 6
WJOG13219G: The Efficacy and Safety of FOLFOXIRI or Doublet plus Anti-VEGF Therapy in Previously Untreated BRAFV600E Mutant Metastatic Colorectal Cancer: A Multi-Institutional Registry-Based Study (BRACELET Study)
2022 · Keitaro Shimozaki, Kenro Hirata, et al. · Clinical Colorectal Cancer · 4
Works count: 66
Citation count: 596
H-index: 12
I10-index: 16
Year
Topic
Type